BioGend Therapeutics Market Cap

BioGend Therapeutics has a market cap or net worth of 3.86 billion as of June 13, 2025. Its market cap has decreased by -14.21% in one year.

Market Cap

3.86B

Enterprise Value

3.31B

Revenue

179.57M

Ranking

n/a

PE Ratio

n/a

Stock Price

30.85

Market Cap Chart

Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 3.86B, an increase of 42.38%. That is a compound annual growth rate of 6.08%.

Market Cap History

Date	Market Cap	% Change
Jun 12, 2025	3.86B	-7.58%
Dec 31, 2024	4.18B	-11.18%
Dec 29, 2023	4.71B	109.50%
Dec 30, 2022	2.25B	-18.50%
Dec 30, 2021	2.76B	-22.86%
Dec 31, 2020	3.57B	46.27%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	183.96B
Caliway Biopharmaceuticals	149.82B
Bora Pharmaceuticals Co., LTD.	83.79B
Lotus Pharmaceutical	60.99B
Polaris Group	30.66B
Lumosa Therapeutics	28.02B
Center Laboratories	27.60B
Oneness Biotech	27.55B

Market Cap Rankings